CORIFACT 250
Google image searchProduct monograph
Active ingredient
factor xiii, 250 UNIT/VIAL
DIN: 02418738
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: FACTOR XIII CONCENTRATE
Schedule: Schedule D
Company: CSL BEHRING CANADA INC
Date: 03-APR-2014
ATC:
- B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
- B02B — VITAMIN K AND OTHER HEMOSTATICS (ATC, ATC/DDD)
- B02BD — Blood coagulation factors (ATC, ATC/DDD)
- B02BD07 — COAGULATION FACTOR XIII (ATC/DDD)
Reference brand drug: Corifact
